Am J Transplant, Volume 5, Suppl 3 Archives - Page 40 of 170 - ATC Abstracts

2015 American Transplant Congress
National Outcomes of Kidney Transplantation from Diabetic Donors
J. Cohen,¹ P. Reese,¹ P. Porrett,² R. Bloom,¹ K. Forde,³ D. Sawinski.¹
¹Renal Division, Univ. of Penn, Philadelphia, PA; ²Dept of Surgery, Univ. of Penn, Philadelphia, PA; ³Division of Gastroenterology, Univ. of Penn, Philadelphia, PA.
Despite limited outcomes data, kidneys from diabetic donors are being increasingly used in the USA. To compare outcomes in recipients of kidneys from diabetic versus…
2015 American Transplant Congress
Impact of Type of Tacrolimus Assay on Therapeutic Drug Monitoring: Need for Standardization
M. Singh, S. Anwar, D. Brennan, R. Delos Santos.
Internal Medicine/Nephrology, Washington University School of Medicine, St. Louis, MO.
Background: Multiple assays are available for measuring tacrolimus (FK) levels and these are not currently standardized. A designated laboratory transitioned their FK assay from Enzyme…
2015 American Transplant Congress
Return to Work and Occupational Infection Risks in Transplant Recipients
R. Avery,¹ D. Ostrander,¹ S. Shoham,¹ S. Alp,² N. Lu,¹ C. Cave,¹ E. Kraus,³ K. Marr.¹
¹Infectious Disease, Johns Hopkins, Baltimore, MD; ²Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey; ³Nephrology, Johns Hopkins, Baltimore, MD.
Background: Counseling is commonly provided to transplant recipients who are planning to return to work, regarding potential infection risks in the workplace. However, the nature…
2015 American Transplant Congress
Pre-Transplant Desensitization Protocol and Cancer Risk in Kidney Transplantation
I. Revuelta,^1,2,3 R. Ferreira,¹ C. Canha,¹ P. Piselli,⁴ D. Verdirosi,⁴ V. Tubita,² E. De Sousa,¹ F. Diekmann,^1,2,3 M. Lozano,^2,5 J. Cid,⁵ E. Palou,⁶ J. Martorell,⁶ A. Alcaraz,⁷ D. Serraino,⁸ F. Oppenheimer,^1,2,3 J. Campistol.^1,2,3
¹Renal Transplant Unit, Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain; ²IDIBAPS, Barcelona, Spain; ³REDinREN. Carlos III Royal Institute. Ministry of Health, Madrid, Spain; ⁴Dipartamento di Epidemiologia e Ricerca Pre-Clinica, INMI “L. Spallanzani” IRCCC, Rome, Italy; ⁵Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Spain; ⁶Department of Immunology, Hospital Clinic, Barcelona, Spain; ⁷Department of Urology, Hospital Clinic, Barcelona, Spain; ⁸IRCCS Centro di Riferimento Oncologico, Aviano, Italy.
Introduction: Desensitization (DS) in kidney transplant is a current therapy for all cause of incompatible living donor kidney transplants (LDKT). The impact in cancer risk…
2015 American Transplant Congress
The Impact of Ischemia/Reperfusion Injury On Liver Allografts from Deceased After Cardiac Death Versus Deceased After Brain Death Donors
B. Sayed, J. Xu, A. Casas-Ferreira, P. Srinivasan, N. Heaton, Y. Ma, C. Legido-Quigley, S. Fuggle, W. Jassem.
1Liver Transplant Unit, Institute of Liver Studies, King's College Hospital, London, United Kingdom; Department of Transplant Surgery, Emory University, Atlanta, United Kingdom; Institute of Pharmaceutical Science, King's College Hospital, London, United Kingdom; Department of Analytical Chemistry, University of Salamanca, Salamanca, Spain; Nuffield Department of Surgery, University of Oxford, Oxford, United Kingdom.
Background and Aims:The shortage of appropriate organs for transplantation has led to the use of organs from donors after cardiac death. The pathophysiologic processes associated…
2015 American Transplant Congress
Outcomes Following Endovascular Treatment of Hepatic Artery Stenosis Following Liver Transplantation
J. Seal,¹ H. Bohorquez,¹ L. Le,² W. Terral,² A. Cohen,¹ I. Carmody,¹ D. Bruce,¹ T. Reichman,¹ E. Ahmed,¹ W. Sternbergh,² G. Loss.¹
¹Multi-Organ Transplant Institute, Ochsner Health System, New Orleans, LA; ²Department of Surgery, Ochsner Health Systems, New Orleans, LA.
Endovascular treatment of hepatic artery stenosis (HAS) after liver transplantation offers a less invasive alternative to surgical revision or retransplantation. However, outcomes following endovascular treatment…
2015 American Transplant Congress
Birth Weight as a Marker of Nephron Mass: Impact on Renal Allograft Function
T. Schachtner,^1,2 P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charité Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.
Nephron number has been considered a major determinant of renal allograft function and outcome. It has been demonstrated that low birth weights give rise to…
2015 American Transplant Congress
Learning from Failures: A 7-Year Analysis of a Multi-Institutional Kidney Paired Donation Registry
D. Fumo,^1,2 V. Kapoor,¹ L. Reece,² S. Rees,² J. Kopke,² S. Stepkowski,¹ C. Smith,^1,2 M. Rees.^1,2
¹University of Toledo Medical Center, Toledo, OH; ²Alliance for Paired Donation, Maumee, OH.
Failure to convert computer-identified possible Kidney Paired Donation (KPD) exchanges into transplants has prevented KPD from reaching its full potential. The purpose of this study…
2015 American Transplant Congress
The Impact of Preoperative Antimicrobial Prophylaxis on Device-Related Infections in Recipients of Long-Term Mechanical Circulatory Support (MCS)
I. El Lakkis,¹ K. Lietz,² C. Derber,¹ U. Kelly,¹ C. Wilson,¹ A. Hoedt,² P. Bourasssa,² B. Smith,² M. McGrath,² J. Herre,² M. Mooney.¹
¹Eastern Virginia Medical School, Norfolk, VA; ²Sentara Norfolk General Hospital, Norfolk, VA.
Purpose: Although preoperative antimicrobial prophylaxis is recommended for patients undergoing long-term MCS device implantation, there is a lack of consensus as to the optimal preoperative…
2015 American Transplant Congress
Inadequate Overall Immunosuppression Is a Risk for Late Acute Rejection Despite Alemtuzumab Induction in Simultaneous Pancreas Kidney Transplant Recipients
J. Bank,¹ M. Mallat,¹ P. van der Boog,¹ D. Braat,² J. Ringers,² M. Vergunst,³ S. Heidt,³ F. Claas,³ M. Reinders,¹ J. de Fijter.¹
¹Nephrology, LUMC, Leiden, Netherlands; ²Surgery, LUMC, Leiden, Netherlands; ³IHB, LUMC, Leiden, Netherlands.
Introduction: Simultaneous pancreas-kidney transplantation (SPK) has become the treatment of choice for patients with end-stage renal disease due to Type 1 Diabetes Mellitus. SPK is…